Gladstone NOW: The Campaign Join Us on the Journey✕
The COVID-19 pandemic poses unprecedented challenges for communities around the world. As the virus continues to spread, COVID-19 is having severe public health and economic effects and has created urgent funding needs worldwide.
To help funders make immediate and strategic investments, Gladstone Institutes and Give2Asia hosted a webinar to provide insight into the pandemic. This webinar combines the biomedical research perspective with recommendations on the difference philanthropy can make in both this and future pandemics.
Melanie Ott, MD, PhD, is a senior investigator at Gladstone Institutes. She uses state-of-the-art organoids to model the infected human lung in a dish, and help scientists understand at a single-cell level how the coronavirus damages lung tissue and how to prevent this.
Aqeela Jogee is the vice president of family philanthropy at Give2Asia. She is responsible for managing the philanthropic services that Give2Asia provides to families to strengthen local communities and grassroots organizations across 25 countries in Asia.
Deborah Kan is the executive editor and founder of Being Patient, an online health platform focused on single-subject long-term diseases. Prior to founding Being Patient, she was a journalist based in Asia and worked for both The Wall Street Journal and Reuters.
Based in San Francisco’s Mission Bay neighborhood, Gladstone Institutes is an independent state-of-the-art biomedical research institution that empowers world-class scientists to find new pathways to cures for various diseases from Alzheimer’s to heart failure. Last year Gladstone celebrated 40 years dedicated to discovery.
Based in the San Francisco Bay Area, Give2Asia is an international nonprofit that serves as a strategic partner and ally working on the ground in more than 23 countries across the Asia Pacific. Their role is to strengthen the work of local organizations and mobilize support through philanthropic giving from individuals, family foundations, and corporations.
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
In this video, Gladstone scientists share how they used stem cells, gene editing, and AI to identify a gene driving heart defects in Down syndrome—and how reducing its levels in mice restored normal heart development, offering hope for future treatments
Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Pollard Lab Srivastava Lab AI Big Data CRISPR/Gene Editing Human Genetics Stem Cells/iPSCsIn this video, Steve Finkbeiner and Jeremy Linsley showcase Gladstone’s groundbreaking “thinking microscope”—an AI-powered system that can design, conduct, and analyze experiments autonomously to uncover new insights into diseases like Alzheimer’s, Parkinson’s, and ALS.
Gladstone Experts ALS Alzheimer’s Disease Parkinson’s Disease Neurological Disease Finkbeiner Lab AI Big DataIn this animated short, Deepak Srivastava explains how scientists can reprogram ordinary skin or blood cells back in time—turning them into induced pluripotent stem cells which are capable of becoming any cell type in the body.
Gladstone Experts Stem Cells/iPSCs